- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
OCREVUS - 920mg/23ml - 1x23ml
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AA36 | BioTech | Ocrelizumab - 920mg/23ml | 12314 | 27625/1 | OCREVUS | 920mg/23ml | 1x23ml | Injectable solution | Infusion | Omnipharma | Roche Diagnostics GmbH | Germany | 1,095,034,629 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 10/11/20 |